| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.042 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0064 | 0.9 |